申请人:ENSEMBLE THERAPEUTICS CORPORATION
公开号:US20150005319A1
公开(公告)日:2015-01-01
The invention relates generally to macrocyclic compounds of formula I and their therapeutic use. More particularly, the invention relates to macrocyclic compounds that modulate the activity of IL-17 and/or are useful in the treatment of medical conditions, such as inflammatory diseases and other IL-17-associated disorders.
本发明涉及公式I的大环化合物及其治疗用途。更具体地,本发明涉及调节IL-17活性或用于治疗医疗情况(例如炎症性疾病和其他IL-17相关疾病)的大环化合物。